Related Experiment Videos
Advances in small-intestine transplantation
1Section of Transplantation Surgery, Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Transplantation
|June 18, 2004
Summary
Intestinal transplantation is now a leading treatment for intestinal failure, with tacrolimus improving outcomes. Advances in patient selection and surgical techniques have led to better survival rates and nutritional autonomy worldwide.
Area of Science:
- Gastroenterology and Hepatology
- Transplant Surgery
- Immunology
Background:
- Intestinal transplantation is a critical intervention for life-threatening intestinal failure.
- Early challenges in intestinal transplantation included technical and immunological hurdles.
- The advent of tacrolimus significantly advanced the field by addressing immunological issues.
Purpose of the Study:
- To review the advancements in intestinal transplantation.
- To highlight the impact of improved surgical and immunosuppressive strategies.
- To discuss the current status and future directions in intestinal transplantation.
Main Methods:
- Review of historical data and clinical outcomes in intestinal transplantation.
- Analysis of the role of immunosuppression, particularly tacrolimus.
- Examination of patient selection criteria and standardized surgical/postoperative protocols.
Main Results:
- Significant improvements in patient and graft survival over the last decade.
- Widespread achievement of nutritional autonomy in hundreds of patients globally.
- Demonstrated gradual but notable increases in patient survival, especially in recent years.
Conclusions:
- Intestinal transplantation has evolved into a viable treatment option due to key advancements.
- Standardized protocols and improved immunosuppression have enhanced success rates.
- Further research into immune responses is crucial for developing novel antirejection therapies and improving long-term outcomes.